Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist licensed in the UK for type 2 diabetes treatment, administered once weekly by subcutaneous injection
If someone told you 40 units without telling you the concentration, they didnt tell you the dose
Future trials should also measure important outcomes such as the clinical signs and symptoms of vitamin B12 deficiency, health related-quality of life, socioeconomic effects, and report adverse events adequately
Glycemic category was determined by investigators on the basis of available information (for example, medical records, concomitant medication, and blood glucose variables) and in accordance with American Diabetes Association criteria, 30 which for prediabetes includes fasting plasma glucose levels of 100 mg/dL (5.6 mmol/L) to 125 mg/dL (6.9 mmol/L) or HbA 1c levels of 5.76.4% (3947 mmol/L), and for type 2 diabetes includes fasting plasma glucose levels of 126 mg/dL (7.0 mmol/L) or HbA 1c levels 6.5% (48 mmol/L)
Kojic acid targets localized pigmentation or dark spots